Resources from the same session
Statistical and study design considerations for dose-finding and dose optimisation in early-phase oncology trials
Presenter: Pavel Mozgunov
Session: The quest for dosage and combination optimisation in early drug development
Resources:
Slides
Webcast
Project Optimus: FDA’s implementation of the (draft) guidance in practice and implications for drug developers
Presenter: Sinan Sarac
Session: The quest for dosage and combination optimisation in early drug development
Resources:
Slides
Webcast
Practical approaches to perform dose and combination optimisation in early phase trials, from academic/cooperative group perspective
Presenter: Stefan Symeonides
Session: The quest for dosage and combination optimisation in early drug development
Resources:
Slides
Webcast
Role of pharmacogenomics, pharmacokinetics, and pharmacodynamics for dose optimisation in oncology drug development
Presenter: George P. Patrinos
Session: The quest for dosage and combination optimisation in early drug development
Resources:
Slides
Webcast